UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000004205
Receipt No. R000004947
Scientific Title Open labeled, single arm, multi centered, phase II trial to evaluate the efficacy and safety of combination therapy of rituximab and cladribine for previously untreated patients with advanced staged extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and nodal marginal zone B-cell lymphoma
Date of disclosure of the study information 2010/09/15
Last modified on 2012/06/28 11:04:30

No. Disposal Last modified on Item of update
1 Insert 2010/09/14 16:21:32
2 Update 2010/11/04 09:41:38 Recruitment status
3 Update 2011/01/25 15:31:38 UMIN ID1
4 Update 2012/06/28 11:04:30

Key inclusion criteria
Key inclusion criteria

Contact us.